# Entrada Therapeutics, Inc. (TRDA)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/TRDA/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 875.0K | $ -39.72M | $ -41.74M | $ 49.75M | $ 270.85M |
| 2025 | $ 26.03M | $ -147.19M | $ -132.65M | $ 50.93M | $ 306.13M |
| 2024 | $ 221.55M | $ 68.98M | $ -47.00M | $ 59.21M | $ 428.68M |
| 2023 | $ 139.50M | $ -7.23M | $ 145.09M | $ 68.23M | $ 242.36M |
| 2022 | $ 0 | $ -105.70M | $ -107.99M | $ 25.94M | $ 212.55M |
| 2021 | $ 0 | $ -60.81M | $ -65.90M | $ 0 | $ 298.72M |
| 2020 | $ 0 | $ -33.79M | $ -35.54M | $ 0 | $ -41.49M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.18 |
| Liabilities / Eq | 0.24 |
| Current Ratio | 13.90 |

## Other views

- [Metrics](https://sponda.capital/en/TRDA.md)
- [Charts](https://sponda.capital/en/TRDA/charts.md)
- [Compare](https://sponda.capital/en/TRDA/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-13.
